Stakeholder Workshop: Join us in shaping the future of clinical trials!

Creating a collaborative environment integrated by a diversity of stakeholders is vital to move forward...
Read More

EU-PEARL’s second GAM is about to kick off in a virtual format

Around 300 Consortium members are called to attend EU-PEARL second General Assembly Meeting (GAM) organised...
Read More

The “magic” of public-private partnerships

Key note by Francesco Patalano (Novartis) and Daniel Prieto-Alhambra (University of Oxford). Albeit our different...
Read More

Aude Mouline, mother of Titouan, 10, diagnosed with NF

I work as a marketing and sales director for a large hospitality company and have...
Read More

Activities to delve into patient engagement take center stage this September

EU-PEARL is taking further steps to ensure that patients will be at the centre in...
Read More

A comprehensive document on platform trials is now available

The domain of EU-PEARL’s research, Integrated Research Platforms (IRPs) and platform trials is relatively new...
Read More

“Beyond COVID-19, our collective effort will ensure that many more patients benefit from platform trials”

As the biomedical sector rapidly mobilizes to address the novel coronavirus pandemic, we are encouraged...
Read More

EU-PEARL plan to foster patient engagement in the design of the platform trial framework takes off

Patient centricity is at the core of EU-PEARL’s mission. That is why we are engaging...
Read More

Get to know Juan M Pericàs, member of EU-PEARL scientific coordination team

Physician, specialised in internal medicine, infectious diseases and epidemiology/public health. EU-PEARL’s scientific co-coordinator, giving support...
Read More

Sign up to stay informed

Subscribe here to our newsletter and stay updated on the latest developments: